loder

North America Companion Diagnostics Market

North America Companion Diagnostics Market - By Type: Genetic Tests, Protein Biomarker Tests, Companion Drug Tests; By Application: Oncology, Neurology, Infectious Diseases, Cardiology; By End-user: Hospitals, Clinics, Research Institutes; By Country: USA and Canada
Report Code
CVMI29122567
Published
March 26, 2025
Last Updated
March 26, 2025
Coverage
Healthcare • Healthcare
Analyst-led, consultative delivery
Enterprise-ready licensing options
Fast turnarounds for custom cuts

Market Snapshot

High-signal KPIs designed for executive scanning.
Indicative snapshot. Request sample for full model outputs.
Market Size (latest)
vs. prior year
CAGR
Forecast window:
Forecast Period
2024–2031
Base years: 2019–2023
Coverage Depth
Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.
nan
nan
nan

Key Players

  • Roche Diagnostics
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Qiagen N.V.
Competitive Dashboard Preview
Shortlist strategic accounts and benchmark positioning.
Loading…
Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.
Refine View
Opportunity Index
Directional signals for prioritization and scenario framing.
Interactive
Need a board-ready slide? .
Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Table Of Contents

Expandable preview of coverage and chapter structure.
North America Companion Diagnostics Market Report

North America Companion Diagnostics Market Report


    1. North America Companion Diagnostics Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 North America Companion Diagnostics Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. North America Companion Diagnostics Market Research Report - Preface
    1. 2.1 North America Companion Diagnostics Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Type
      2. 2.1.2 By Application
      3. 2.1.3 By End-user
      4. 2.1.4 By Region
    3. North America Companion Diagnostics Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Type, By Application, By End-user, By Country
    3. 3.3. Opportunities – By Type, By Application, By End-user, By Country
    4. 3.4. Trends – By Type, By Application, By End-user, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. North America Companion Diagnostics Market Research Report – DROTs Impact Analysis
    4. North America Companion Diagnostics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. North America Companion Diagnostics Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Genetic Tests
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Protein Biomarker Tests
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Companion Drug Tests
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. North America Companion Diagnostics Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Oncology
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Neurology
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Infectious Diseases
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 6.4 Cardiology
      1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. North America Companion Diagnostics Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Hospitals
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Clinics
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Research Institutes
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. North America Companion Diagnostics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 North America Companion Diagnostics Market - Opportunity Analysis Index, By Type, By Application, By End-user, and Region, 2024 - 2031
    9. North America North America Companion Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Genetic Tests
      2. 9.1.2 Protein Biomarker Tests
      3. 9.1.3 Companion Drug Tests
      9.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Oncology
      2. 9.2.2 Neurology
      3. 9.2.3 Infectious Diseases
      4. 9.2.4 Cardiology
      9.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Hospitals
      2. 9.3.2 Clinics
      3. 9.3.3 Research Institutes
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
      9.5 North America North America Companion Diagnostics Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
      9.6 Regional Trends Analysis
      9.7 North America North America Companion Diagnostics Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Competition Landscape
      10.1 Strategic Dashboard of Top Market Players
      10.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 10.2.1 Roche Diagnostics
      2. 10.2.2 Agilent Technologies
      3. 10.2.3 Thermo Fisher Scientific
      4. 10.2.4 Abbott Laboratories
      5. 10.2.5 Qiagen N.V.
    11. Data Collection Method and Research Approach
    12. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.
Book A Consultation
Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.
Ready to move from data to decision?
Get the report, request a sample, or book a consultative briefing.
New chat message received
×

Need help?

Chat with our team in a minute.